Pierce K. H. Chow

Pierce Chow is Professor and Program Director at the Duke-NUS Medical School and senior consultant surgeon at the National Cancer Centre Singapore and the Singapore General Hospital. He is concurrently a National Medical Research Council (NMRC) funded Senior Clinician-Scientist and founding President of the College of Clinician Scientists, Academy of Medicine Singapore. Pierce leads the multi-disciplinary NMRC TCR National Flagship Program in Liver Cancer and the Biomedical Research Council (BMRC) funded IAF-PP Predictive Platform in Liver Cancer (PuRPOSE) program in collaboration with Samsung Medical Center, South Korea. Pierce was conferred the NMRC National Outstanding Clinician Scientist Award in 2012 for improving clinical outcomes with his research on Liver Cancer. In 2016, he was awarded the NMRC TCR grant for the Flagship Program in Liver Cancer and in 2017, a BMRC IAF-PP grant to develop a patient-specific diagnostic and predictive platform for liver cancer. In 2020, he was awarded an A*STAR IAF-ICP grant to conduct a nation-wide cohort study to develop diagnostics for early detection of hepatocellular carcinoma in high-risk patients. Pierce is also a faculty member at the Genome Institute of Singapore and the SingHealth Duke-NUS Global Health Institute and Research Director at the Institute of Cell and Molecular Biology Singapore. Pierce is also the Chairman, Scientific Advisory Board of AUM Biosciences and Chair of IMbrave050 Steering Committee, Genentech.